The four anti-CD20 drugs used in the U.S. to treat relapsing MS -- ocrelizumab, ofatumumab, and ublituximab (Briumvi; ...

Six months after entering talks with U.S. private equity firm Clayton, Dubilier & Rice (CD&R), Sanofi has closed a deal to ...

The European Union should allow drug prices to rise to U.S. levels in order to attract investment, the bosses of two European ...

The U.S. Food and Drug Administration approved the use of Sanofi and Regeneron's blockbuster drug Dupixent for patients with a type of skin condition, the two companies said on Friday. The agency's ...

The Food and Drug Administration (FDA) is coming under fire for not publicizing its own report into an E. coli outbreak last year that spread across 15 states and infected 89 people, one of whom died.

Despite the severity of the outbreak, the Food and Drug Administration (FDA) never made a public announcement. According to an internal report, the investigation was closed quietly in February ...

Patients who take a common drug for high blood pressure are being urged to check the medication after its manufacturer reported that a mistake in the strength of the dose had been printed on some ...

Well-known baby product maker Gerber Products Company issued a recall reminder in tandem with the Food and Drug Administration (FDA) on April 18 after affected products were still seen on store ...

April 18 (Reuters) - The U.S. Food and Drug Administration approved the use of Sanofi (SASY.PA), opens new tab and Regeneron's (REGN.O), opens new tab blockbuster drug Dupixent for patients with a ...

Newsweek has contacted Blooming Import via email for comment. While reactions to color additives are rare, the FDA requires that all such ingredients be clearly declared on product labels to help ...

President Donald Trump signed an executive order aimed at lowering drug prices and expanding access to affordable medications, according to an April 15 White House Fact Sheet. Through the efforts ...